An observational study in Anterior Cruciate Ligament Reconstruction Rehabilitation, sponsored by Peking University Third Hospital. Enrolling by invitation at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-15.
Sponsored by Peking University Third Hospital · Observational
To evaluate the correlation between wearing time of different braces and short-term functional changes such as knee functional score, knee circumference and postoperative recovery Angle after ACL reconstruction, and provide preliminary evidence and key data for subsequent research on whether and how long it is necessary to wear braces after ACL reconstruction.
Peking University Third Hospital is the lead sponsor of 749 studies on the registry; 270 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients after anterior cruciate ligament reconstruction
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-Patients with acute anterior cruciate ligament injury undergoing anterior cruciate ligament reconstruction
Exclusion Criteria:
-Refused to sign the informed consent
Thigh circumference
Thigh dimension: centimeters(cm)
Time frame: Preoperative, postoperative 3 weeks, 6 weeks, 3 months, 6 months, 9 months
Degree of Joint range of motion
Degree of Joint range of motion
Time frame: Preoperative, postoperative 3 weeks, 6 weeks, 3 months, 6 months, 9 months
Started Jan 2025 (actual). Primary completion is estimated for Sep 2025, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Third Hospital →